So, repotrectinib is this inhibitor that zeroes in on several kinds of kinases. It’s like a superhero for TRK, ROS1, and ALK! It’s mainly used for people with ROS1-positive NSCLC and NTRK-fusion kinds of cancers. Pretty specific, huh? The med comes in these 40 mg capsules.
Not too tiny! First up, you take 160 mg once a day for two weeks. Then it’s two doses a day at 160 mg after that. One bottle holds 60 capsules and lasts you about a month on the recommended dose. Handy, right?
Reviews
There are no reviews yet.